The Drug Development Grant provide research institutions and investigators with project funding to develop and assess new or repurposed therapeutics for motor neurone disease, advancing promising candidates through preclinical research and, where appropriate, into Phase I clinical trials. The grants are structured in two development stages, from identifying and validating a lead therapeutic candidate to
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: